Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients’ data
暂无分享,去创建一个
W. Lau | F. Xia | P. Bie | H. Huan | Da-peng Yang | X. Wen | Li-li Wu | Liang Zhang | Xishu Wang